Allspring Global Investments Holdings LLC Sells 74,138 Shares of Ralliant Corporation $RAL

Allspring Global Investments Holdings LLC lessened its holdings in Ralliant Corporation (NYSE:RAL) by 23.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 242,900 shares of the company’s stock after selling 74,138 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.22% of Ralliant worth $12,441,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Westfuller Advisors LLC purchased a new position in shares of Ralliant in the third quarter worth about $26,000. Palisade Asset Management LLC purchased a new stake in Ralliant during the 3rd quarter valued at about $26,000. UMB Bank n.a. purchased a new stake in Ralliant during the 3rd quarter valued at about $29,000. BOKF NA bought a new position in Ralliant during the 3rd quarter worth approximately $29,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Ralliant during the 3rd quarter worth approximately $30,000.

Insider Buying and Selling

In other news, SVP Amir A. Kazmi purchased 2,545 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were bought at an average cost of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the transaction, the senior vice president directly owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This trade represents a 6.85% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kevin E. Bryant purchased 1,250 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was acquired at an average price of $39.97 per share, with a total value of $49,962.50. Following the completion of the purchase, the director owned 4,653 shares in the company, valued at $185,980.41. This represents a 36.73% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought a total of 8,145 shares of company stock worth $332,233 over the last quarter.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Citigroup lowered their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research report on Friday, February 6th. Zacks Research cut shares of Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Royal Bank Of Canada decreased their target price on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research note on Friday, February 6th. Truist Financial dropped their target price on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Finally, Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Ralliant currently has a consensus rating of “Hold” and an average price target of $50.50.

Ralliant Trading Down 0.2%

Shares of RAL opened at $41.92 on Monday. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $57.02. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. The firm’s 50-day moving average price is $44.96 and its 200-day moving average price is $46.72. The firm has a market capitalization of $4.68 billion and a price-to-earnings ratio of 21.39.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. Ralliant’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were given a $0.05 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. Ralliant’s dividend payout ratio is currently 10.20%.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.